Berberine shows no advantage over placebo for reducing liver and belly fat

A multicenter research effort in China conducted clinical trial testing of oral berberine for six months in diabetes-free adults with obesity and metabolic dysfunction-associated steatotic liver disease. Visceral adipose tissue area and liver fat…

Continue Reading

News Source: medicalxpress.com